Tag:
BG Medicine
Latest Headlines
Latest Headlines
Positive results for biomarker based diagnostic CardioSCORE
Heart attacks and strokes are major cardiovascular events, and are traumatic for patients and their families. Every year in the U.S. around 785,000 people have a first heart attack, and 470,000 who
BG Medicine, Boston Scientific partner on CRT biomarker
BG Medicine and Boston Scientific are partnering on patient-screening technology for cardiac-resynchronization therapy (CRT). They're looking at whether galectin-3 can help identify patients who
Biotechs braving stormy IPO waters to raise cash
A pair of life sciences companies which went public on Friday morning saw their shares surge upward in the afternoon. But the gains came only after each had chopped a huge chunk off their projected
BG withdraws planned IPO
BG Medicine withdrew its planned IPO last Thursday after failing to set a price for the deal. According to an earlier report, the Waltham, MA-based developer of biomarker-based diagnostic tools was
BG Med gets $40M in fourth round
Waltham, MA-based BG Medicine garnered $40 million in its fourth venture round. New investors Legg Mason Capital Management, GE Asset Management and SMALLCAP World Fund joined current investors
